STAT1 and breast carcinoma: Although ODZ10117 inhibited the tyrosine phosphorylation of STAT3, it did not significantly affect other STAT family proteins, including STAT1, STAT5, and STAT6, in breast cancer cells and Hodgkin’s lymphoma cells (Figure 5 and Supplementary Figure S10A).